Literature DB >> 10540350

Modulation of E2F activity in primary mouse B cells following stimulation via surface IgM and CD40 receptors.

E W Lam1, J Glassford, J van der Sman, L Banerji, A R Pizzey, N Shaun, B Thomas, G G Klaus.   

Abstract

Since signals via CD40 and the B cell receptor are known to synergize to induce B cell activation, we have analyzed the pocket protein/E2F complexes in mouse B lymphocytes following stimulation by anti-IgM, anti-CD40, alone or together. We find that E2F4 and DP1 form the predominant E2F heterodimers in the G0 and G1 phases of the cell cycle, complexed with hypophosphorylated p130. During late G1 and S phase this complex is replaced by at least three different E2F complexes, one of which is an E2F complex containing p107 or pRB as well as two "free" E2F complexes consisting of E2F4/DP1 and E2F1-3/DP1. These effects were mirrored by the levels and phosphorylation status of the three pocket proteins. We also observed an increase in electrophoretic mobility of DP1 and E2F4 as B cells progressed from G0 into early G1, resulting from their dephosphorylation. This is known to correlate with a decrease in DNA binding capacity of these proteins and could also be important for derepression of genes negatively regulated through E2F sites in their promoters. These results therefore indicate that the pRB/E2F pathway integrates proliferative signals emanating from the sIgM and CD40 receptors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10540350     DOI: 10.1002/(SICI)1521-4141(199910)29:10<3380::AID-IMMU3380>3.0.CO;2-C

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  7 in total

1.  The Histone Demethylase LSD1 Regulates B Cell Proliferation and Plasmablast Differentiation.

Authors:  Robert R Haines; Benjamin G Barwick; Christopher D Scharer; Parimal Majumder; Troy D Randall; Jeremy M Boss
Journal:  J Immunol       Date:  2018-09-19       Impact factor: 5.422

2.  Induction of TAp73 by platinum-based compounds to overcome drug resistance in p53 dysfunctional chronic lymphocytic leukemia.

Authors:  Sanne H Tonino; Chantal E Mulkens; Jacoline van Laar; Ingrid A M Derks; Guangli Suo; Fransien Croon-de Boer; Marinus H J van Oers; Eric Eldering; Jean Y Wang; Arnon P Kater
Journal:  Leuk Lymphoma       Date:  2015-01-21

3.  Disruption of mutually negative regulatory feedback loop between interferon-inducible p202 protein and the E2F family of transcription factors in lupus-prone mice.

Authors:  Ravichandran Panchanathan; Hong Xin; Divaker Choubey
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

Review 4.  Signaling by CD40 and its mimics in B cell activation.

Authors:  G A Bishop; B S Hostager
Journal:  Immunol Res       Date:  2001       Impact factor: 4.505

5.  Inhibition of cell cycle progression by dual phosphatidylinositol-3-kinase and mTOR blockade in cyclin D2 positive multiple myeloma bearing IgH translocations.

Authors:  J Glassford; D Kassen; J Quinn; C Stengel; K Kallinikou; A Khwaja; K L Yong
Journal:  Blood Cancer J       Date:  2012-01-13       Impact factor: 11.037

6.  Promiscuous and lineage-specific roles of cell cycle regulators in haematopoiesis.

Authors:  Stephen S Myatt; Eric W-F Lam
Journal:  Cell Div       Date:  2007-02-12       Impact factor: 5.130

7.  MicroRNA-155 is essential for the optimal proliferation and survival of plasmablast B cells.

Authors:  Giuseppina Arbore; Tom Henley; Laura Biggins; Simon Andrews; Elena Vigorito; Martin Turner; Rebecca Leyland
Journal:  Life Sci Alliance       Date:  2019-05-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.